A team of researchers from Inserm has just demonstrated the therapeutic potential of triheptanoin in ten patients with Huntington’s disease. Derivatives of this triglyceride, with its unique composition, might be able to slow the progression of the disease by improving the energy metabolism of the brain. Huntington’s disease is a genetic disease that affects approximately 5,000 people in France, with another 10,000 individuals at risk … Continue reading Therapeutic potential of triheptanoin confirmed for Huntington’s disease.